12:20 - 13:30
Session 14: Checkpoint Inhibitors for Cancer Metastasis, Speaker Steven J. O'Day, MD, Sponsored by Bristol-Myers Squibb
Room: Crystal Ballroom
Industry Sponsored Lunch Session (Non-CME)
12:20 - 12:40
14-01
Dual Immune Checkpoint Inhibition for the First Line Treatment of BRAF Wild Type and BRAF Mutant Metastatic Melanoma.
Steven O'Day